Molecular design of two sterol 14α-demethylase homology models and their interactions with the azole antifungals ketoconazole and bifonazole

No abstract is available for this paper.

• Publication year

  2005

• Venue

  J. Comput. Aided Mol. Des.

• Publication date

  2005-03-01

• Fields of study

  Biology, Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1007/s10822-005-3692-7PMID 16059669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of models for cytochrome P450 2A5 as well as two of its mutants.

  2005cited by this paper
• Development of models for cytochrome P450 2A5 as well as two of its mutants.

  2005cited by this paper
• Modeling and interactions of Aspergillus fumigatus lanosterol 14-alpha demethylase 'A' with azole antifungals.

  2004cited by this paper
• Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi.

  2003cited by this paper
• Molecular basis of resistance to azole antifungals.

  2002cited by this paper
• Synthesis, antifungal activity, and molecular modeling studies of new inverted oxime ethers of oxiconazole.

  2002cited by this paper
• Antifungal agents. 10. New derivatives of 1-[(aryl)[4-aryl-1H-pyrrol-3-yl]methyl]-1H-imidazole, synthesis, anti-candida activity, and quantitative structure-analysis relationship studies.

  2002cited by this paper
• Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.

  2001cited by this paper
• Molecular modelling of 17 alpha-hydroxylase-17,20-lyase.

  2001cited by this paper
• Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors

  2001cited by this paper
• Differential inhibition of human CYP3A4 and Candida albicans CYP51 with azole antifungal agents.

  2000cited by this paper
• A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals.

  2000cited by this paper
• Characterization of the mouse lanosterol 14alpha-demethylase (CYP51), a new member of the evolutionarily most conserved cytochrome P450 family.

  2000cited by this paper
• Chiral azole derivatives. 4. Enantiomers of bifonazole and related antifungal agents: synthesis, configuration assignment, and biological evaluation.

  2000cited by this paper
• Characteristics of the heterologously expressed human lanosterol 14α‐demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents

  1999cited by this paper
• A theoretical study of electronic factors affecting hydroxylation by model ferryl complexes of cytochrome P-450 and horseradish peroxidase

  1999cited by this paper
• Molecular modelling of lanosterol 14 alpha-demethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: quantitative structure-activity relationships (QSARs) within two related series of antifungal azole derivatives.

  1999cited by this paper
• Current and Emerging Azole Antifungal Agents

  1999cited by this paper
• Generation of a complete, soluble, and catalytically active sterol 14 alpha-demethylase-reductase complex.

  1999cited by this paper
• Construction of a model of the Candida albicans lanosterol 14-alpha-demethylase active site using the homology modelling technique.

  1998cited by this paper
• Antifungal agents: chemotherapeutic targets and immunologic strategies

  1996cited by this paper
• Heme-Containing Oxygenases.

  1996cited by this paper
• Theoretical study of the vibrational spectra of the transition metal carbonyls M(CO)6 [M=Cr, Mo, W], M(CO)5 [M=Fe, Ru, Os], and M(CO)4 [M=Ni, Pd, Pt]

  1995cited by this paper
• Efficient molecular numerical integration schemes

  1995cited by this paper
• Modeling cytochrome P450 14 alpha demethylase (Candida albicans) from P450cam.

  1994cited by this paper
• Modeling cytochrome P450 14α demethylase (Candida albicans) from P450cam

  1994cited by this paper
• Stereoisomers of ketoconazole: preparation and biological activity.

  1992cited by this paper
• ELECTRONIC STRUCTURE CALCULATIONS ON WORKSTATION COMPUTERS: THE PROGRAM SYSTEM TURBOMOLE

  1989cited by this paper
• Density-functional exchange-energy approximation with correct asymptotic behavior.

  1988cited by this paper
• Overview of medically important antifungal azole derivatives

  1988cited by this paper
• Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.

  1988cited by this paper

• Characterization of Prototheca CYP51/ERG11 as a possible target for therapeutic drugs.

  2021cites this paper
• Design, synthesis, antifungal activity, and QM/MM docking study of two azole derivatives with indole ring

  2020cites this paper
• Antifungal screening and in silico mechanistic studies of an in‐house azole library

  2019cites this paper
• The binding mechanism between azoles and FgCYP51B, sterol 14α-demethylase of Fusarium graminearum.

  2018cites this paper
• Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors.

  2017cites this paper
• Synthesis and mechanistic evaluation of novel N'-benzylidene-carbohydrazide-1H-pyrazolo[3,4-b]pyridine derivatives as non-anionic antiplatelet agents.

  2017cites this paper
• Sub-lethal effects and bioconcentration of the human pharmaceutical clotrimazole in rainbow trout (Oncorhynchus mykiss).

  2016cites this paper
• Coumarin Antifungal Lead Compounds from Millettia thonningii and Their Predicted Mechanism of Action

  2016cites this paper
• Analytical and semipreparative chiral separation of cis-itraconazole on cellulose stationary phases by high-performance liquid chromatography.

  2016cites this paper
• Binding of azole drugs to heme: A combined MS/MS and computational approach

  2015cites this paper
• Synthesis, biological evaluation and structure-activity correlation study of a series of imidazol-based compounds as Candida albicans inhibitors.

  2014cites this paper
• Bayesian models for screening and TB Mobile for target inference with Mycobacterium tuberculosis.

  2014cites this paper
• Resistance to antifungals that target CYP51

  2014cites this paper
• Evaluation of structural features in fungal cytochromes P450 predicted to rule catalytic diversification.

  2013cites this paper
• Azole-carbodithioate hybrids as vaginal anti-Candida contraceptive agents: design, synthesis and docking studies.

  2013cites this paper
• Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans.

  2012cites this paper
• Fungal cytochrome P450 sterol 14α-demethylase (CYP51) and azole resistance in plant and human pathogens

  2012cites this paper
• S279 Point Mutations in Candida albicans Sterol 14-α Demethylase (CYP51) Reduce In Vitro Inhibition by Fluconazole

  2012cites this paper
• Discovery of a new class of dithiocarbamates and rhodanine scaffolds as potent antifungal agents: synthesis, biology and molecular docking

  2012cites this paper
• Identification of novel CYP2A6 inhibitors by virtual screening.

  2011cites this paper
• Homology modeling and screening of new 14α-demethylase inhibitor (DMI) fungicides based on optimized expression of CYP51 from Ustilago maydis in Escherichia coli.

  2010cites this paper
• Impact of Absolute Stereochemistry on the Antiangiogenic and Antifungal Activities of Itraconazole.

  2010cites this paper
• Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.

  2010cites this paper
• Molecular Modelling of Estrogen-Producing Enzymes CYP450 Aromatase and 17beta-Hydroxysteroid Dehydrogenase Type 1

  2009cites this paper
• The binding of lignans, flavonoids and coumestrol to CYP450 aromatase: a molecular modelling study.

  2009influential citation
• Expression and homology modelling of sterol 14alpha-demethylase of Magnaporthe grisea and its interaction with azoles.

  2009cites this paper
• Bulky 1,4-benzoxazine derivatives with antifungal activity.

  2009cites this paper
• Expression and Homology Modeling of Sterol 14alpha-Demethylase from Magnaporthe Grisea

  2008cites this paper
• Extensive Chemometric Investigations of the Multidrug Resistance in Strains of the Phytopathogenic Fungus Penicillium Digitatum

  2008cites this paper
• Targeting human DNA polymerase α for the inhibition of keratinocyte proliferation. Part 1. Homology model, active site architecture and ligand binding

  2008cites this paper
• Targeting human DNA polymerase alpha for the inhibition of keratinocyte proliferation. Part 1. Homology model, active site architecture and ligand binding.

  2008cites this paper
• Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14alpha-demethylase (CYP51).

  2008cites this paper
• A computational study of the substrate conversion and selective inhibition of aldosterone synthase

  2008cites this paper
• Structure-activity relationship of uniconazole, a potent inhibitor of ABA 8'-hydroxylase, with a focus on hydrophilic functional groups and conformation.

  2008cites this paper
• AIScore Chemically Diverse Empirical Scoring Function Employing Quantum Chemical Binding Energies of Hydrogen-Bonded Complexes

  2008cites this paper
• In silico description of differential enantioselectivity in methoxychlor O-demethylation by CYP2C enzymes.

  2008cites this paper
• X-ray Structure of 4,4′-Dihydroxybenzophenone Mimicking Sterol Substrate in the Active Site of Sterol 14α-Demethylase (CYP51)*♦

  2008cites this paper
• Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics

  2007cites this paper
• Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 Inhibitors

  2007cites this paper
• Using Protein Homology Models for Structure-Based Studies: Approaches to Model Refinement

  2006cites this paper
• Target-related applications of first principles quantum chemical methods in drug design.

  2006cites this paper
• Functional interaction of nitrogenous organic bases with cytochrome P450: a critical assessment and update of substrate features and predicted key active-site elements steering the access, binding, and orientation of amines.

  2006cites this paper
• Three Dimensional-Quantitative Structure Activity Relationship (3D-QSAR) Analysis Of Human CYP51 Inhibitors

  2006influential citation